Prof. (Mrs.) Marili Funmilayo Zubair

Prof. (Mrs.) Marili Funmilayo Zubair

Post
Professor
Department
Industrial Chemistry
Email
marilizub@unilorin.edu.ng
Office Address
Room 13, First Floor, Block 6, Industrial Chemistry Department, University of Ilorin, Ilorin
Teaching and Research Area
Natural Products, Synthesis/Organic Chemistry , Medicinal and Chemoinformatics

Qualifications

  • Ph.D, (Organic Chemistry): Ladoke Akintola University of Technology, Ogbomoso (2011)
  • M.Sc, (Organic Chemistry): Bayero University, Kano (2001)
  • B.Sc. (Hons), Chemistry, Bayero University, Kano (1996)
  • Senior Secondary School Certificate (WAEC) (1990)

Professional Affiliations

  • Fellow: Chemical Society of Nigeria (FCSN)
  • Member, Institute of Chartered Chemists of Nigeria (ICCON)
  • Member Science Association of Nigeria (SAN)
  • Member, National Association of Women Academics, University of Ilorin Chapter (NAWACs)
  • Member, Nigeria Institute of Management (NIM)

Undergraduate Teaching

  • ICH 205: Organic Chemistry I
  • ICH 327: Organic Chemistry II
  • ICH305: Industrial Chemical Technology
  • ICH351: Basic Concepts in Drug Design
  • ICH355: Experimental Organic Chemistry
  • ICH438: Detergent and Cosmetic Chemistry
  • ICH427: Undergraduate Seminar
  • ICH457: Fertilizer and Agrochemicals
  • ICH463: Industrial Chemistry Laboratory II
  • ICH499: Undergraduate Special Project

Postgraduate Teaching

  • ICH802: Advanced Applied Spectroscopy
  • ICH809: Graduate Seminar
  • ICH812: Advanced Colour and Dyestuff Chemistry
  • ICH821: Advanced Natural Product II
  • ICH 839: Dissertation
  • ICH 999: Ph.D. Thesis

Research Interest

  • My research focuses on understanding drug resistance through computational and molecular modeling approaches, integrating molecular docking, molecular dynamics simulations, MMGBSA free energy calculations, ADMET predictions, and mutagenesis analysis. By employing density functional theory (DFT) to analyze molecular interactions at an atomic level, I aim to unravel the structural and energetic determinants influencing drug efficacy and resistance mechanisms. This multidisciplinary approach enables the rational design of novel therapeutic compounds with optimized pharmacokinetics, toxicity profiles, and enhanced binding affinity. Through computational strategies, I seek to contribute to the development of effective drug candidates, bridging the gap between structural biology and pharmaceutical sciences to combat resistance in various disease models.